405 related articles for article (PubMed ID: 26065893)
1. γ-Secretase directly sheds the survival receptor BCMA from plasma cells.
Laurent SA; Hoffmann FS; Kuhn PH; Cheng Q; Chu Y; Schmidt-Supprian M; Hauck SM; Schuh E; Krumbholz M; Rübsamen H; Wanngren J; Khademi M; Olsson T; Alexander T; Hiepe F; Pfister HW; Weber F; Jenne D; Wekerle H; Hohlfeld R; Lichtenthaler SF; Meinl E
Nat Commun; 2015 Jun; 6():7333. PubMed ID: 26065893
[TBL] [Abstract][Full Text] [Related]
2. γ-Secretase inhibition increases efficacy of BCMA-specific chimeric antigen receptor T cells in multiple myeloma.
Pont MJ; Hill T; Cole GO; Abbott JJ; Kelliher J; Salter AI; Hudecek M; Comstock ML; Rajan A; Patel BKR; Voutsinas JM; Wu Q; Liu L; Cowan AJ; Wood BL; Green DJ; Riddell SR
Blood; 2019 Nov; 134(19):1585-1597. PubMed ID: 31558469
[TBL] [Abstract][Full Text] [Related]
3. Endogenous soluble receptors sBCMA and sTACI: biomarker, immunoregulator and hurdle for therapy in multiple myeloma.
Meinl E; Krumbholz M
Curr Opin Immunol; 2021 Aug; 71():117-123. PubMed ID: 34330018
[TBL] [Abstract][Full Text] [Related]
4. Single Site
Huang HW; Chen CC; Lin KI; Hsu TL; Wong CH
ACS Chem Biol; 2024 Jan; 19(1):153-161. PubMed ID: 38085681
[TBL] [Abstract][Full Text] [Related]
5. Human Plasmacytoid Dendritic Cells Display and Shed B Cell Maturation Antigen upon TLR Engagement.
Schuh E; Musumeci A; Thaler FS; Laurent S; Ellwart JW; Hohlfeld R; Krug A; Meinl E
J Immunol; 2017 Apr; 198(8):3081-3088. PubMed ID: 28283566
[TBL] [Abstract][Full Text] [Related]
6. Increased BCMA expression in lupus marks activated B cells, and BCMA receptor engagement enhances the response to TLR9 stimulation.
Kim J; Gross JA; Dillon SR; Min JK; Elkon KB
Autoimmunity; 2011 Mar; 44(2):69-81. PubMed ID: 21250838
[TBL] [Abstract][Full Text] [Related]
7. Unveiling the link between genetic alterations in gamma secretase and BCMA surface density in multiple myeloma.
Cowan AJ; Green DJ
Br J Haematol; 2024 Feb; 204(2):391-392. PubMed ID: 38014717
[TBL] [Abstract][Full Text] [Related]
8. Genetic defects of gamma-secretase genes in a multiple myeloma patient with high and dysregulated BCMA surface density: A case report.
Cattaneo I; Valgardsdottir R; Cavagna R; Spinelli O; Bartoletti-Stella A; Capellari S; Galli M; Golay J
Br J Haematol; 2024 Feb; 204(2):571-575. PubMed ID: 37957838
[TBL] [Abstract][Full Text] [Related]
9. Nirogacestat: First Approval.
Keam SJ
Drugs; 2024 Mar; 84(3):355-361. PubMed ID: 38409573
[TBL] [Abstract][Full Text] [Related]
10. Anti-BCMA CAR-T cells therapy for a patient with extremely high membrane BCMA expression: a case report.
Li D; Que Y; Ding S; Hu G; Wang W; Mao X; Wang Y; Li C; Huang L; Zhou J; Zhang W; Xiao M
J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36137648
[TBL] [Abstract][Full Text] [Related]
11. B-cell maturation antigen (BCMA) activation exerts specific proinflammatory effects in normal human keratinocytes and is preferentially expressed in inflammatory skin pathologies.
Alexaki VI; Pelekanou V; Notas G; Venihaki M; Kampa M; Dessirier V; Sabour-Alaoui S; Stathopoulos EN; Tsapis A; Castanas E
Endocrinology; 2012 Feb; 153(2):739-49. PubMed ID: 22166983
[TBL] [Abstract][Full Text] [Related]
12. Cellular membrane-based vesicles displaying a reconstructed B cell maturation antigen for multiple myeloma therapy by dual targeting APRIL and BAFF.
He C; Zhang M; Liu L; Han Y; Xu Z; Xiong Y; Yan F; Su D; Chen H; Zheng Y; Cheng F
Acta Biomater; 2022 Apr; 143():406-417. PubMed ID: 35218967
[TBL] [Abstract][Full Text] [Related]
13. The Role of B-Cell Maturation Antigen in the Biology and Management of, and as a Potential Therapeutic Target in, Multiple Myeloma.
Sanchez E; Smith EJ; Yashar MA; Patil S; Li M; Porter AL; Tanenbaum EJ; Schlossberg RE; Soof CM; Hekmati T; Tang G; Wang CS; Chen H; Berenson JR
Target Oncol; 2018 Feb; 13(1):39-47. PubMed ID: 29230672
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of B cell maturation antigen as a target for antibody drug conjugate mediated cytotoxicity in multiple myeloma.
Lee L; Bounds D; Paterson J; Herledan G; Sully K; Seestaller-Wehr LM; Fieles WE; Tunstead J; McCahon L; Germaschewski FM; Mayes PA; Craigen JL; Rodriguez-Justo M; Yong KL
Br J Haematol; 2016 Sep; 174(6):911-22. PubMed ID: 27313079
[TBL] [Abstract][Full Text] [Related]
15. γ-secretase inhibitors augment efficacy of BCMA-targeting bispecific antibodies against multiple myeloma cells without impairing T-cell activation and differentiation.
Chen H; Yu T; Lin L; Xing L; Cho SF; Wen K; Aardalen K; Oka A; Lam J; Daley M; Lu H; Munshi N; Anderson KC; Tai YT
Blood Cancer J; 2022 Aug; 12(8):118. PubMed ID: 35973981
[TBL] [Abstract][Full Text] [Related]
16. Identification of proteoglycans as the APRIL-specific binding partners.
Ingold K; Zumsteg A; Tardivel A; Huard B; Steiner QG; Cachero TG; Qiang F; Gorelik L; Kalled SL; Acha-Orbea H; Rennert PD; Tschopp J; Schneider P
J Exp Med; 2005 May; 201(9):1375-83. PubMed ID: 15851487
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the receptor BCMA as a biomarker in systemic lupus erythematosus patients.
Salazar-Camarena DC; Palafox-Sánchez CA; Cruz A; Marín-Rosales M; Muñoz-Valle JF
Sci Rep; 2020 Apr; 10(1):6236. PubMed ID: 32277232
[TBL] [Abstract][Full Text] [Related]
18. Redirecting T-cell Activity with Anti-BCMA/Anti-CD3 Bispecific Antibodies in Chronic Lymphocytic Leukemia and Other B-cell Lymphomas.
Martens AWJ; Rietveld JM; de Boer R; Peters FS; Ngo A; van Mil LWHG; de Heer K; Spaargaren M; Verkleij CPM; van de Donk NWCJ; Adams HC; Eldering E; van Noesel CJM; Verona R; Kater AP
Cancer Res Commun; 2022 May; 2(5):330-341. PubMed ID: 36875718
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor 9 activation induces expression of membrane-bound B-cell activating factor (BAFF) on human B cells and leads to increased proliferation in response to both soluble and membrane-bound BAFF.
Abu-Rish EY; Amrani Y; Browning MJ
Rheumatology (Oxford); 2013 Jul; 52(7):1190-201. PubMed ID: 23436580
[TBL] [Abstract][Full Text] [Related]
20. Soluble B-cell maturation antigen in multiple myeloma.
Costa BA; Ortiz RJ; Lesokhin AM; Richter J
Am J Hematol; 2024 Apr; 99(4):727-738. PubMed ID: 38270277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
